DIMENSIONAL FUND ADVISORS LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$222,000
-84.1%
431,387
-77.3%
0.00%
-100.0%
Q2 2020$1,398,000
-46.2%
1,903,004
-31.7%
0.00%0.0%
Q1 2020$2,598,000
-57.3%
2,785,162
-6.7%
0.00%
-50.0%
Q4 2019$6,091,000
-32.7%
2,985,489
-5.3%
0.00%
-50.0%
Q3 2019$9,044,000
-65.2%
3,151,132
-7.0%
0.00%
-60.0%
Q2 2019$25,982,000
-37.7%
3,387,612
+7.9%
0.01%
-41.2%
Q1 2019$41,707,000
-7.8%
3,138,257
+8.1%
0.02%
-15.0%
Q4 2018$45,229,000
-20.4%
2,903,093
+0.4%
0.02%
-9.1%
Q3 2018$56,839,000
-33.2%
2,892,539
-2.5%
0.02%
-35.3%
Q2 2018$85,113,000
+15.3%
2,965,704
-5.0%
0.03%
+9.7%
Q1 2018$73,830,000
+16.5%
3,121,775
+5.7%
0.03%
+19.2%
Q4 2017$63,381,000
+0.9%
2,954,691
+11.2%
0.03%
-3.7%
Q3 2017$62,813,000
+34.4%
2,655,959
+11.9%
0.03%
+22.7%
Q2 2017$46,745,000
+21.5%
2,372,868
+29.6%
0.02%
+22.2%
Q1 2017$38,474,000
+35.7%
1,831,450
+21.5%
0.02%
+28.6%
Q4 2016$28,342,000
+1.0%
1,507,562
+12.2%
0.01%
-6.7%
Q3 2016$28,056,000
-18.3%
1,343,714
-0.2%
0.02%
-25.0%
Q2 2016$34,344,000
+10.7%
1,346,545
+14.8%
0.02%
+5.3%
Q1 2016$31,023,000
-33.9%
1,172,910
+6.9%
0.02%
-34.5%
Q4 2015$46,939,000
+64.7%
1,097,219
+2.1%
0.03%
+52.6%
Q3 2015$28,502,000
-18.6%
1,075,167
+2.4%
0.02%
-9.5%
Q2 2015$35,008,000
+12.3%
1,050,339
+12.1%
0.02%
+5.0%
Q1 2015$31,180,000
+15.5%
936,883
+41.9%
0.02%
+11.1%
Q4 2014$26,987,000
+20.1%
660,329
-0.4%
0.02%
+12.5%
Q3 2014$22,470,000
-0.7%
663,130
-1.2%
0.02%0.0%
Q2 2014$22,620,000
-11.3%
671,026
-0.2%
0.02%
-15.8%
Q1 2014$25,502,000
+28.6%
672,694
-1.0%
0.02%
+26.7%
Q4 2013$19,832,000
-14.6%
679,193
+0.3%
0.02%
-25.0%
Q3 2013$23,210,000
+10.6%
677,067
+6.5%
0.02%0.0%
Q2 2013$20,977,000635,8530.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,044,783$34,770,0004.41%
1492 Capital Management LLC 101,582$3,381,0001.96%
Tekla Capital Management LLC 680,862$22,659,0000.90%
ARBOR CAPITAL MANAGEMENT LLC 186,495$6,207,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 210,000$6,989,0000.73%
Pergamon Offshore Advisors, L.P. 18,711$623,0000.60%
Partner Investment Management, L.P. 11,594$386,0000.58%
Penn Capital Management Company, LLC 426,937$14,208,0000.56%
HighPoint Advisor Group LLC 10,609$360,0000.55%
EAGLE ASSET MANAGEMENT INC 2,461,980$81,934,0000.47%
View complete list of ACORDA THERAPEUTICS INC shareholders